Alnylam Pharmaceuticals · 2 days ago
Scientist, Research (Targeted Delivery)
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, seeking a Scientist to join their Research Department. The role involves advancing RNAi therapeutics through targeted delivery by designing and executing analytical assays and characterizing ligand-receptor interactions.
Responsibilities
Contribute to an interdisciplinary team focused on expanding targeted delivery into new cell types and tissues
Design, optimize, and execute a wide range of analytical and biophysical assays to assess the identity, purity, stability, and aggregation propensity of ligand candidates
Analyze and interprete complex data from various techniques to guide the selection and engineering of ligand with optimal biophysical properties
Establish tools, techniques, and assays to identify and characterize new receptors to unlock targeted delivery into new cell types and tissues
Transparently communicate results with key stakeholders throughout the organization
Qualification
Required
PhD in Biochemistry, Molecular Biology, Cell Biology, or related field
0-3 years of experience in biopharma setting
Expertise in receptor biology and characterizing ligand/receptor interactions using ELISA, Western blot, FP, ITC, and BLI/SPR
Strong background in protein biophysics to characterize the ligand using DSF, DLS SEC
Excellent communication skills (both written and oral) are essential
Preferred
Familiarity with high-throughput automation setup
Benefits
Comprehensive benefits including medical, dental, and vision coverage
Life and disability insurance
A lifestyle reimbursement program
Flexible spending and health savings accounts
A 401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Recent News
Clinical Trials Arena
2026-01-16
Longevity.Technology
2026-01-14
2026-01-13
Company data provided by crunchbase